Latest Content

A UCLA study found patients with cancer who used biosimilars paid less out of pocket, and their insurers paid far less, than those on brand-name biologics.

Researchers are studying how genetics and environmental factors may influence lung cancer risk and could help shape the future of screening and treatment.

In the phase 2/3 STAR-TREC trial, 78.5% of patients given long-course chemoradiotherapy kept their rectum at 12 months, versus 60.6% with short-course radiotherapy.

In the phase 3 SHARE trial, salvage radiation given in 26 sessions kept cancer in check as well as 33 sessions did, with more late bowel side effects.

Rasonque offers a new targeted treatment option for metastatic pancreatic cancer. Dr. Kristin Higgins explains the approval, trial results and side effects.

I have worked alongside Lori Ranallo for 23 years and watched her guide patients with breast cancer from diagnosis through survivorship and beyond.

GYN oncologist Dr. Ami Vaidya, explains what gynecologic cancers are, why awareness matters and how patients can learn to recognize symptoms.

Nona Baker discusses the misdiagnoses that came first, why families need support and what has changed since.

A friend’s 28-year cancer journey taught one woman how to find hope, stay optimistic and live fully after her own incurable cancer diagnosis.

A testicular cancer survivor shares his story of early detection, embracing failure, and redefining success through hard-won life lessons.

Dolly Parton has died at 80 following a brief battle with cancer. Learn what is known about her diagnosis, legacy and resources for those affected.

In a new video Q&A with CURE, Dr. Silverman answers the most searched childhood leukemia questions.

An incoming medical oncologist at the University of Cincinnati on how patient values shape treatment, and what precision medicine can now target.